Stockscreener 앱 받기
0.301
7.31%
0.0205
시간 외 거래:
.29
-0.011
-3.65%
전일 마감가:
$0.2805
열려 있는:
$0.314
하루 거래량:
1.05M
Relative Volume:
2.55
시가총액:
$22.03M
수익:
$3.38M
순이익/손실:
$-15.06M
주가수익비율:
-1.2836
EPS:
-0.2345
순현금흐름:
$-15.50M
1주 성능:
-50.57%
1개월 성능:
-47.91%
6개월 성능:
-70.34%
1년 성능:
-74.40%
1일 변동 폭
$0.28
$0.3216
1주일 범위
$0.2771
$0.6341
52주 변동 폭
$0.2771
$1.40
Icecure Medical Ltd Stock (ICCM) Company Profile
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.301 | 20.53M | 3.38M | -15.06M | -15.50M | -0.2345 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Icecure Medical Ltd 주식(ICCM)의 최신 뉴스
Fund Flows: Should I set a stop loss on IceCure Medical LtdShort Setup & Verified Trade Idea Suggestions - baoquankhu1.vn
IceCure Medical Ltd. (ICCM) Q2 Earnings Surpass Estimates - MSN
ICCM SEC FilingsIcecure Medical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
IceCure (NASDAQ: ICCM) offers 8M shares with 16M private warrants - Stock Titan
Epoch updates 45.8% IceCure Medical (ICCM) stake and board change - Stock Titan
IceCure Medical (ICCM) prices $4M share sale with concurrent warrants - Stock Titan
IceCure prices $4M direct offering, concurrent private placement - MSN
IceCure Medical (ICCM) Secures $4M Through Direct Offering - gurufocus.com
IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement - ChartMill
[Form 3] IceCure Medical Ltd. Initial Statement of Beneficial Ownership - Stock Titan
Huang Yang reports RSUs and options in IceCure Medical (NASDAQ: ICCM) - Stock Titan
IceCure Medical (NASDAQ: ICCM) director Chan Vincent Chun Hung files Form 3 - Stock Titan
IceCure Medical (ICCM) VP discloses shares, RSUs and option grants - Stock Titan
IceCure Medical (ICCM) COO discloses share, option and RSU stakes - Stock Titan
IceCure Medical (ICCM) VP details RSUs and stock option grants - Stock Titan
IceCure Medical (ICCM) CFO details shares, RSUs and options in Form 3 - Stock Titan
IceCure Medical (ICCM) director discloses shares and options in Form 3 - Stock Titan
IceCure Medical (ICCM) VP Naum Muchnik details insider share and option holdings - Stock Titan
IceCure Medical (ICCM) VP details share, option and RSU holdings - Stock Titan
IceCure Medical (ICCM) CEO details share, RSU and option stakes - Stock Titan
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates - Bitget
IceCure Medical Posts Strong 5-Year Kidney Cancer Cryoablation Data From ICESECRET Trial - TipRanks
IceCure Medical Ltd Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study - marketscreener.com
IceCure Medical (ICCM) Reports Positive Outcomes in Kidney Cance - gurufocus.com
IceCure Medical (Nasdaq: ICCM) unveils 5-year kidney cancer data - Stock Titan
IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates (2026-03-25) - Seeking Alpha
IceCure names Meir Peleg as CFO - Medical Buyer
[EFFECT] IceCure Medical Ltd. SEC Filing - Stock Titan
IceCure Appoints Meir Peleg as Chief Financial Officer - citybiz
IceCure Medical Names New CFO and Plans Key Leadership Changes Amid ProSense® Growth - TipRanks
IceCure Medical (NASDAQ: ICCM) hires Meir Peleg as new CFO - Stock Titan
IceCure Appoints Meir Peleg as Chief Financial Officer (2026-03-24) - Seeking Alpha
[EFFECT] IceCure Medical Ltd.... | ICCM SEC FilingForm EFFECT - Stock Titan
Dip Buying: Is IceCure Medical Ltd subject to activist investor interest2026 Selloffs & Precise Buy Zone Identification - baoquankhu1.vn
Published on: 2026-03-22 01:37:56 - baoquankhu1.vn
Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic U.S. ... By GuruFocus - Investing.com Canada
Ideas Watch: What dividend growth rate does IceCure Medical Ltd offerM&A Rumor & Breakout Confirmation Trade Signals - baoquankhu1.vn
Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Rec - GuruFocus
IceCure Medical (NASDAQ: ICCM) registers $100M shelf for shares and warrants - Stock Titan
IceCure Medical (NASDAQ: ICCM) registers 9.74M shares from outstanding warrants - Stock Titan
History Review: Is IceCure Medical Ltd stock a good dividend stock2026 Volume & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 earnings call transcript - MSN
IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 Earnings Call Transcript - Insider Monkey
IceCure reports net loss of USD 15,057,000 in 2025 - Medical Buyer
Icecure Medical Rides FDA, ASBRS Wins to Growth - TipRanks
IceCure Medical Discloses Resignation of Director Li Haixiang - TipRanks
IceCure Medical (ICCM) director Li Haixiang steps down from board - Stock Titan
IceCure Medical (ICCM) Q4 2025 Earnings Transcript - AOL.com
IceCure Medical Ltd Announces Resignation of Li Haixiang as Member of the Board of Directors, Effective March 17, 2026 - marketscreener.com
IceCure Medical 2025 Financial Results Review | ProSense System UpdatesNews and Statistics - IndexBox
IceCure Medical (ICCM) Fourth Quarter 2025 Earnings Call Transcript - Bitget
Icecure Medical Ltd (ICCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.03%
자본화:
|
볼륨(24시간):